Which of the following local anesthetics is a short-acting drug?

Questions 262

ATI RN

ATI RN Test Bank

Safety Pharmacology Across the Lifespan ATI Quizlet Questions

Question 1 of 5

Which of the following local anesthetics is a short-acting drug?

Correct Answer: A

Rationale: In the context of safety pharmacology, understanding the duration of action of local anesthetics is crucial for safe and effective patient care. In this question, the correct answer is A) Procaine, which is a short-acting local anesthetic. Procaine has a rapid onset but a short duration of action, making it ideal for procedures that require temporary anesthesia. Option B) Tetracaine is a long-acting local anesthetic known for its prolonged duration of action. It is commonly used for spinal anesthesia and epidural anesthesia due to its long-lasting effects. Option C) Bupivacaine is an intermediate-acting local anesthetic with a longer duration of action compared to procaine. It is often used for surgical procedures and postoperative pain management. Option D) Ropivacaine is also an intermediate-acting local anesthetic similar to bupivacaine, providing a longer duration of anesthesia compared to short-acting agents like procaine. Understanding the differences in the duration of action of local anesthetics is essential for healthcare professionals to select the most appropriate agent based on the procedure and patient needs. This knowledge ensures optimal pain management, minimal risk of side effects, and overall patient safety during anesthesia administration across the lifespan.

Question 2 of 5

Characteristics of carbachol include all of the following EXCEPT:

Correct Answer: B

Rationale: In this question, the correct answer is B) It causes mydriasis. Carbachol is a cholinomimetic agent that acts on both nicotinic and muscarinic receptors in the body. It is commonly used to decrease intraocular pressure in conditions like glaucoma by causing constriction of the pupil (miosis), not mydriasis (dilation of the pupil). Option A is incorrect because carbachol does indeed decrease intraocular pressure by constricting the pupil and increasing aqueous humor outflow. Option C is incorrect as carbachol exerts its effects primarily through muscarinic receptors, not nicotinic receptors. Option D is incorrect as carbachol is actually not resistant to acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. Educationally, understanding the characteristics of pharmacological agents like carbachol is crucial for healthcare professionals, especially in the context of safety pharmacology across different age groups. This knowledge helps in appropriate prescribing, monitoring for side effects, and ensuring patient safety when using such medications.

Question 3 of 5

Indicate cholinesterase activator:

Correct Answer: A

Rationale: In the context of safety pharmacology, understanding cholinesterase activators is crucial as they play a significant role in various physiological processes. In this question, the correct answer is A) Pralidoxime. Pralidoxime is a cholinesterase reactivator used in cases of organophosphate poisoning to reverse the toxic effects by reactivating inhibited cholinesterase enzymes. Option B) Edrophonium is a cholinesterase inhibitor used to diagnose myasthenia gravis by temporarily increasing the availability of acetylcholine at the neuromuscular junction. Option C) Pilocarpine is a cholinergic agonist used to treat conditions like glaucoma and dry mouth by stimulating muscarinic receptors. Option D) Isoflurophate is an irreversible cholinesterase inhibitor used in ophthalmology to constrict the pupil for diagnostic purposes. Educationally, understanding the differences between cholinesterase activators and inhibitors is crucial for safe pharmacological practice. By knowing the specific actions of each drug, healthcare professionals can make informed decisions when managing patients with conditions related to cholinergic systems.

Question 4 of 5

The toxic effects of a large dose of nicotine include all of the following EXCEPT:

Correct Answer: A

Rationale: The correct answer is A) Hypotension and bradycardia. Nicotine, when taken in large doses, acts as a stimulant initially, leading to hypertension and tachycardia. However, as the dose increases, it can cause central nervous system depression, leading to hypotension and bradycardia. Option B) Convulsions, coma, and respiratory arrest are potential toxic effects of a large dose of nicotine due to its impact on the central nervous system. Option C) Skeletal muscle depolarization blockade and respiratory paralysis can occur with nicotine poisoning, affecting neuromuscular transmission and leading to muscle weakness and respiratory failure. Option D) Hypertension and cardiac arrhythmias are early effects of nicotine toxicity due to its stimulant properties on the cardiovascular system. Educational context: Understanding the toxic effects of nicotine is crucial for healthcare professionals, especially in cases of accidental ingestion or intentional overdose. By knowing the range of symptoms associated with nicotine toxicity, healthcare providers can provide appropriate treatment and interventions to manage the effects and prevent further harm.

Question 5 of 5

Atropine is highly selective for:

Correct Answer: D

Rationale: Atropine is a medication that acts as a non-selective antagonist of muscarinic acetylcholine receptors. Therefore, the correct answer is D) All of the above because atropine is not highly selective for any specific muscarinic receptor subtype. It blocks all five muscarinic receptor subtypes (M₁, M₂, M₃, M₄, M₅) to varying degrees. Option A) M₁ receptor subtype, Option B) M₂ receptor subtype, and Option C) M₃ receptor subtype are incorrect because atropine does not show high selectivity for any specific muscarinic receptor subtype. Understanding the non-selective nature of atropine's action is crucial in the context of safety pharmacology as it helps healthcare providers anticipate and manage the broad range of effects that atropine can have on different organ systems across the lifespan. In clinical practice, atropine is commonly used to treat bradycardia, organophosphate poisoning, and to dilate the pupils during eye examinations. Knowing that atropine acts on multiple muscarinic receptor subtypes can guide healthcare professionals in assessing potential side effects and interactions when administering this medication to patients of different age groups.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions